|
1
|
Kim B: Palliative radiotherapy in a
patient with pulmonary adenoid cystic carcinoma. Cancer Res Treat.
39:185–188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fang J, Bao YY, Zhou SH, Luo XM, Yao HT,
He JF and Wang QY: Recurrent prognostic factors and expression of
GLUT-1, PI3K and p-Akt in adenoid cystic carcinomas of the head and
neck: Clinicopathological features and biomarkers of adenoid cystic
carcinoma. Oncol Lett. 4:1234–1240. 2012.PubMed/NCBI
|
|
3
|
Papaspyrou G, Hoch S, Rinaldo A, Rodrigo
JP, Takes RP, van Herpen C, Werner JA and Ferlito A: Chemotherapy
and targeted therapy in adenoid cystic carcinoma of the head and
neck: A review. Head Neck. 33:905–911. 2011. View Article : Google Scholar
|
|
4
|
Patel D, Shukla S and Gupta S: Apigenin
and cancer chemo-prevention: Progress potential and promise
(review). Int J Oncol. 30:233–245. 2007.
|
|
5
|
Oishi M, Iizumi Y, Taniguchi T, Goi W,
Miki T and Sakai T: Apigenin sensitizes prostate cancer cells to
Apo2L/TRAIL by targeting adenine nucleotide translocase-2. PLoS
One. 8:e559222013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG,
Yoo HJ and Lee SJ: Apigenin induces c-Myc-mediated apoptosis in FRO
anaplastic thyroid carcinoma cells. Mol Cell Endocrinol.
369:130–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao X, Liu B, Cao W, Zhang W, Zhang F,
Zhao H, Meng R, Zhang L, Niu R, Hao X and Zhang B: Autophagy
inhibition enhances apigenin-induced apoptosis in human breast
cancer cells. Chin J Cancer Res. 25:212–222. 2013.PubMed/NCBI
|
|
8
|
Melstrom LG, Salabat MR, Ding XZ, Milam
BM, Strouch M, Pelling JC and Bentrem DJ: Apigenin inhibits the
GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt
pathway in human pancreatic cancer cells. Pancreas. 37:426–431.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He J, Xu Q, Wang M, Li C, Qian X, Shi Z,
Liu LZ and Jiang BH: Oral administration of apigenin inhibits
metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian
tumor model. Int J Mol Sci. 13:7271–7282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chan LP, Chou TH, Ding HY, Chen PR, Chiang
FY, Kuo PL and Liang CH: Apigenin induces apoptosis via tumor
necrosis factor receptor- and Bcl-2-mediated pathway and enhances
susceptibility of head and neck squamous cell carcinoma to
5-fluorouracil and cisplatin. Biochim Biophys Acta. 1820:1081–1091.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Melstrom LG, Salabat MR, Ding XZ, Strouch
MJ, Grippo PJ, Mirzoeva S, Pelling JC and Bentrem DJ: Apigenin
down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF
in human pancreatic cancer cells. J Surg Res. 167:173–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang J, Zhou Q, Liu LZ, Xia C, Hu X, Shi X
and Jiang BH: Apigenin inhibits tumor angiogenesis through
decreasing HIF-1alpha and VEGF expression. Carcinogenesis.
28:858–864. 2007. View Article : Google Scholar
|
|
13
|
Liu LZ, Fang J, Zhou Q, Hu X, Shi X and
Jiang BH: Apigenin inhibits expression of vascular endothelial
growth factor and angiogenesis in human lung cancer cells:
Implication of chemoprevention of lung cancer. Mol Pharmacol.
68:635–643. 2005.PubMed/NCBI
|
|
14
|
Li LF, Zhou SH, Zhao K, Wang SQ, Wu QL,
Fan J, Cheng KJ and Ling L: Clinical significance of FDG
single-photon emission computed tomography: Computed tomography in
the diagnosis of head and neck cancers and study of its mechanism.
Cancer Biother Radiopharm. 23:701–714. 2008. View Article : Google Scholar
|
|
15
|
Wu XH, Chen SP, Mao JY, Ji XX, Yao HT and
Zhou SH: Expression and significance of hypoxia-inducible factor-1α
and glucose transporter-1 in laryngeal carcinoma. Oncol Lett.
5:261–266. 2013.
|
|
16
|
Yan SX, Luo XM, Zhou SH, Bao YY, Fan J, Lu
ZJ, Liao XB, Huang YP, Wu TT and Wang QY: Effect of antisense
oligodeoxynucleotides glucose transporter-1 on enhancement of
radiosensitivity of laryngeal carcinoma. Int J Med Sci.
10:1375–1386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu YY, Bao YY, Zhou SH and Fan J: Effect
on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2
cell line by antisense glucose transporter-1. Arch Med Res.
43:395–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu TQ, Fan J, Zhou L and Zheng SS:
Effects of suppressing glucose transporter-1 by an antisense
oligodeoxynucleotide on the growth of human hepatocellular
carcinoma cells. Hepatobiliary Pancreat Dis Int. 10:72–77. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bruno A, Siena L, Gerbino S, Ferraro M,
Chanez P, Giammanco M, Gjomarkaj M and Pace E: Apigenin affects
leptin/leptin receptor pathway and induces cell apoptosis in lung
adenocarcinoma cell line. Eur J Cancer. 47:2042–2051. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shukla S and Gupta S: Apigenin-induced
cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and
loss of cyclin D1 associated retinoblastoma dephosphorylation in
human prostate cancer cells. Cell Cycle. 6:1102–1114. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu Y, Mao Y, Chen H, Lin Y, Hu Z, Wu J,
Xu X, Xu X, Qin J and Xie L: Apigenin promotes apoptosis, inhibits
invasion and induces cell cycle arrest of T24 human bladder cancer
cells. Cancer Cell Int. 13:542013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng PW, Chiang LC and Lin CC: Apigenin
induced apoptosis through p53-dependent pathway in human cervical
carcinoma cells. Life Sci. 76:1367–1379. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bao YY, Zhou SH, Fan J and Wang QY:
Anticancer mechanism of apigenin and the implications of GLUT-1
expression in head and neck cancers. Future Oncol. 9:1353–1364.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim JI, Choi KU, Lee IS, Choi YJ, Kim WT,
Shin DH, Kim K, Lee JH, Kim JY and Sol MY: Expression of hypoxic
markers and their prognostic significance in soft tissue sarcoma.
Oncol Lett. 9:1699–1706. 2015.PubMed/NCBI
|
